| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/06/2010 | US20100113355 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 05/06/2010 | US20100113354 Therapeutic agent comprising vasohibin |
| 05/06/2010 | US20100113349 Extracellular matrix-binding proteins from staphylococcus aureus |
| 05/06/2010 | US20100113345 Preparation of low bleeding anticoagulant fusion protein and its use |
| 05/06/2010 | US20100113344 Method Of Detection Of Nucleic Acids With A Specific Sequence Composition |
| 05/06/2010 | US20100113343 Methods involving lef-1 regulation and use of lef-1 or compounds altering lef-1 signalling for treating or preventing diseases |
| 05/06/2010 | US20100113342 Antimicrobial kinocidin compositions and methods of use |
| 05/06/2010 | US20100113340 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 05/06/2010 | US20100113339 Serum albumin binding proteins with long half-lives |
| 05/06/2010 | US20100113338 Prophylactic or therapeutic agent for corneal/conjunctival disease |
| 05/06/2010 | US20100113335 Compositions and methods for treatement of cancer |
| 05/06/2010 | US20100113327 Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein |
| 05/06/2010 | US20100113303 Polypeptide Display Libraries and Methods of Making and Using Thereof |
| 05/06/2010 | US20100113300 T cell receptor display |
| 05/06/2010 | US20100113291 Complexes of nadp with the protein maba of mycobacterium tuberculosis or with mutants thereof, and their uses for designing and screening antibiotics |
| 05/06/2010 | US20100112709 Highly sensitive method for detecting protein in food |
| 05/06/2010 | US20100112701 Reductase, gene thereof and method of using the same |
| 05/06/2010 | US20100112699 Porous composite biomaterials and production method of the same |
| 05/06/2010 | US20100112661 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same |
| 05/06/2010 | US20100112660 Method for Derivatization of Proteins Using Hydrostatic Pressure |
| 05/06/2010 | US20100112657 Nucleic acids and constructs for increasing galactose catabolism and methods therefor |
| 05/06/2010 | US20100112607 Methods for determining active ingredients in pro-drug peg protein conjugates with releasable peg reagents (in vitro de-pegylation) |
| 05/06/2010 | US20100112602 Protein-Protein Interaction Biosensors and Methods of Use Thereof |
| 05/06/2010 | US20100112591 Tumor Suppressor Gene |
| 05/06/2010 | US20100112582 Gene encoding labyrinthin, a marker for cancer |
| 05/06/2010 | US20100112562 Mutation Implicated in Abnormality of Cardiac Sodium Channel Function |
| 05/06/2010 | US20100112080 MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN |
| 05/06/2010 | US20100112071 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 05/06/2010 | US20100111998 Hiv vaccines based on env of multiple clades of hiv |
| 05/06/2010 | US20100111996 Papaya Mosaic Virus-Based Vaccines for Influenza |
| 05/06/2010 | US20100111993 Recombinant vaccines and use thereof |
| 05/06/2010 | US20100111990 Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women |
| 05/06/2010 | US20100111989 Rsv f-protein and its use |
| 05/06/2010 | US20100111988 Small peptide for anti-angiogenesis and use thereof |
| 05/06/2010 | US20100111986 WT1 HLA Class II-Binding Peptides and Compositions and Methods Comprising Same |
| 05/06/2010 | US20100111978 Conjugates between a variant staphylococcal enterotoxin e superantigen and a targeting antibody that binds to a cancer-associated cell surface structure |
| 05/06/2010 | US20100111977 Methods and compositions for treatment of myotonic dystrophy |
| 05/06/2010 | US20100111974 Treatment of Cachexia |
| 05/06/2010 | US20100111964 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 05/06/2010 | US20100111961 Compositions and methods for diagnosing or treating psoriasis |
| 05/06/2010 | US20100111958 Notch-Binding Agents and Antagonists and Methods of Use Thereof |
| 05/06/2010 | US20100111956 antigen polypeptide for the diagnosis and/or treatment of ovarian cancer |
| 05/06/2010 | US20100111952 Treatment of autoimmune disorders |
| 05/06/2010 | US20100111949 Methods and compositions for the treatment of proliferative diseases |
| 05/06/2010 | US20100111948 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 05/06/2010 | US20100111940 Compositions containing alpha-1-antitrypsin and methods for use |
| 05/06/2010 | US20100111933 Acid soluble proteins from micellar casein |
| 05/06/2010 | US20100111903 Compositions produced using enteric pathogens and methods of use |
| 05/06/2010 | US20100111899 Materials and Methods for Immunizing Against FIV Infection |
| 05/06/2010 | US20100111871 Photoacoustic probes and methods of imaging |
| 05/06/2010 | CA2742064A1 Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor |
| 05/06/2010 | CA2742014A1 Toll-like receptor 3 antagonists |
| 05/06/2010 | CA2741964A1 Novel tools for the production of glycosylated proteins in host cells |
| 05/06/2010 | CA2741834A1 Fibronectin type iii domain based scaffold compositions, methods and uses |
| 05/06/2010 | CA2741823A1 Leukolectins and uses thereof |
| 05/06/2010 | CA2739568A1 Purification of acidic proteins using ceramic hydroxyapatite chromatography |
| 05/06/2010 | CA2738615A1 Treating diabetes melitus using insulin injections with less than daily injection frequency |
| 05/06/2010 | CA2736350A1 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny |
| 05/05/2010 | EP2182066A2 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 05/05/2010 | EP2182065A2 Staphylococcus epidermidis antigens |
| 05/05/2010 | EP2182064A1 Gene expressed in prostate cancer |
| 05/05/2010 | EP2182061A1 Novel tumor marker for pancreatic cancer |
| 05/05/2010 | EP2182007A1 Process for preparing human G-CSF |
| 05/05/2010 | EP2182006A2 Compositions and methods for the treatment of immune related diseases |
| 05/05/2010 | EP2182005A1 A gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 05/05/2010 | EP2182004A1 Combination therapy of isotopically labelled chlorotoxin with temozolomide |
| 05/05/2010 | EP2182003A1 Peptide capable of binding to immunoglobulin |
| 05/05/2010 | EP2181731A1 Organic compounds with biological effect as thrombin inhibitor and use of same |
| 05/05/2010 | EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/05/2010 | EP2181712A1 Use of glucagon-like peptide-1 or analogs to abolish catabolic changes after surgery |
| 05/05/2010 | EP2181595A1 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 05/05/2010 | EP2181121A2 Chimeric antigens |
| 05/05/2010 | EP2181120A2 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 05/05/2010 | EP2181119A1 Isoelectric point markers |
| 05/05/2010 | EP2181118A1 Process for the production of pramlintide |
| 05/05/2010 | EP1989304B1 A method of removing a non-metallic protein inhibitor from a liquid pharmaceutical preparation |
| 05/05/2010 | EP1845162B1 DNA sequences having anti-repressor activity |
| 05/05/2010 | EP1842919B1 DNA sequences having anti-repressor activity |
| 05/05/2010 | EP1829971B1 DNA sequences having anti-repressor activity |
| 05/05/2010 | EP1806407B1 DNA sequences having anti-repressor activity |
| 05/05/2010 | EP1790655B1 Biologically active peptides |
| 05/05/2010 | EP1648520B1 Compounds and methods for downregulating the effects of tgf-beta |
| 05/05/2010 | EP1592801B1 Method for identifying activated polymer complexes for secondary site-specific modification of protein target groups. |
| 05/05/2010 | EP1567545B1 Peptides and their use in the treatment of central nervous system damage |
| 05/05/2010 | EP1329522B1 Method of detecting norwalk-like virus (gi) |
| 05/05/2010 | EP1248803B1 Nogo receptor-mediated blockade of axonal growth |
| 05/05/2010 | EP1232157B1 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 05/05/2010 | EP1060261B1 Poly zinc finger proteins with improved linkers |
| 05/05/2010 | EP0935648B1 Improved adenovirus vectors |
| 05/05/2010 | EP0854917B1 Transgenic non-human animals capable of producing heterologous antibodies |
| 05/05/2010 | EP0832299B1 Use of nucleic acid ligands in flow cytometry |
| 05/05/2010 | EP0703783B1 Methods of making immunogenic hla-a2.1 binding peptides |
| 05/05/2010 | CN1982464B Rice blast gene related with virulence and its use |
| 05/05/2010 | CN1976947B Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 05/05/2010 | CN1958794B Method for preparing mutant code cDNA of apoptosis induction ligand related to human tumor necrosis factor, and application |
| 05/05/2010 | CN1958603B Method for purifying human chorionic gonadotropin |
| 05/05/2010 | CN1950511B Plants having improved yield and method for making the same |
| 05/05/2010 | CN1902217B Novel peptide, process for producing the same and pharmaceutical composition containing the peptide |
| 05/05/2010 | CN1861628B Process for separating protein of Chinese medicine |
| 05/05/2010 | CN1816624B Rice transposon gene |